A detailed history of Nuveen Asset Management, LLC transactions in Surmodics Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 42,609 shares of SRDX stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,609
Previous 42,609 -0.0%
Holding current value
$1.62 Million
Previous $1.79 Million 7.76%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$27.44 - $35.56 $1.27 Million - $1.65 Million
-46,270 Reduced 52.06%
42,609 $1.25 Million
Q4 2023

Feb 14, 2024

SELL
$28.47 - $38.49 $360,458 - $487,321
-12,661 Reduced 12.47%
88,879 $3.23 Million
Q3 2023

Nov 14, 2023

BUY
$28.28 - $38.36 $1.26 Million - $1.71 Million
44,470 Added 77.92%
101,540 $3.26 Million
Q2 2023

Aug 14, 2023

BUY
$17.67 - $31.31 $222,695 - $394,599
12,603 Added 28.34%
57,070 $1.79 Million
Q1 2023

May 15, 2023

SELL
$17.13 - $38.52 $7,006 - $15,754
-409 Reduced 0.91%
44,467 $1.01 Million
Q4 2022

Feb 14, 2023

BUY
$29.44 - $37.31 $7,507 - $9,514
255 Added 0.57%
44,876 $1.53 Million
Q3 2022

Nov 14, 2022

SELL
$28.84 - $38.92 $10,526 - $14,205
-365 Reduced 0.81%
44,621 $1.36 Million
Q2 2022

Aug 15, 2022

SELL
$33.25 - $45.11 $44,821 - $60,808
-1,348 Reduced 2.91%
44,986 $1.68 Million
Q1 2022

May 16, 2022

BUY
$40.68 - $49.72 $20,177 - $24,661
496 Added 1.08%
46,334 $1.96 Million
Q4 2021

Feb 14, 2022

SELL
$43.21 - $57.6 $143,543 - $191,347
-3,322 Reduced 6.76%
45,838 $1.98 Million
Q3 2021

Nov 12, 2021

SELL
$52.8 - $60.32 $300,432 - $343,220
-5,690 Reduced 10.37%
49,160 $2.87 Million
Q2 2021

Aug 16, 2021

SELL
$51.29 - $59.15 $220,752 - $254,581
-4,304 Reduced 7.28%
54,850 $2.98 Million
Q1 2021

May 17, 2021

BUY
$42.18 - $56.07 $51,037 - $67,844
1,210 Added 2.09%
59,154 $3.32 Million
Q4 2020

Feb 16, 2021

SELL
$35.18 - $43.52 $134,457 - $166,333
-3,822 Reduced 6.19%
57,944 $2.52 Million
Q3 2020

Nov 16, 2020

SELL
$37.98 - $48.72 $343,187 - $440,233
-9,036 Reduced 12.76%
61,766 $2.4 Million
Q2 2020

Aug 14, 2020

BUY
$31.07 - $44.74 $36,165 - $52,077
1,164 Added 1.67%
70,802 $3.06 Million
Q1 2020

May 14, 2020

SELL
$22.46 - $42.24 $756,452 - $1.42 Million
-33,680 Reduced 32.6%
69,638 $2.32 Million
Q4 2019

Feb 14, 2020

SELL
$39.01 - $47.51 $3.19 Million - $3.89 Million
-81,894 Reduced 44.22%
103,318 $4.28 Million
Q3 2019

Nov 14, 2019

BUY
$38.66 - $47.41 $907,504 - $1.11 Million
23,474 Added 14.51%
185,212 $8.47 Million
Q2 2019

Aug 15, 2019

BUY
$38.23 - $47.43 $6.18 Million - $7.67 Million
161,738 New
161,738 $6.98 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $533M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.